Hepatocellular carcinoma: Current surgical management

Seminars in Oncology

Volumn 28, Issue 5, 2001, Pages 474-486

  Little, Sarah A ^a,b   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

EID: 0034793638     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(01)90140-X     Document Type: Article

References (124)

1. Primary hepatocellular carcinoma
2. An analysis of 412 cases of hepatocellular carcinoma at a Western center
3. Carcinoma of the bifurcation of the hepatic ducts
4. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
5. Transection of the oesophagus for bleeding oesophageal varices
6. Liver resection in cirrhosis of the liver
7. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients
8. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure
9. Bases anatomiques des hepatectomies gauche et droite reglees
10. Results of 90 consecutive hepatectomies for hepatocellular carcinoma: A multivariate analysis of survival
11. Prolonged normothermic ischaemia of human cirrhotic liver during hepatectomy: A preliminary report
12. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study
13. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction
14. Improved survival with resection after transcatheter arterial chemoembolisation (TACE) for unresectable hepatocellular carcinoma
15. Is preoperative hepatic arterial chemoembolisation safe and effective for hepatocellular carcinoma?
16. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment
17. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90 yttrium microspheres
18. Final report on a phase II study of combination cisplatin, interferon alpha, doxorubicin and 5-fluorouracil for inoperable hepatocellular carcinoma
19. Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients
20. Right portal vein embolization in preparation for major hepatic resection
21. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: The ipsilateral approach
22. An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agents for hepatic malignancies
23. Transcatheter chemoembolisation effective for treating hepatocellular carcinoma. A histopathological study
24. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?
25. Influence of preoperative transarterial chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
26. Experience with liver resection after hepatic arterial chemoembolisation for hepatocellular carcinoma
27. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: A retrospective comparison of 138 liver resections
28. Preoperative chemoembolisation of hepatocellular carcinoma: A comparative study
29. Prevention of second primary tumors by an acyclic retnoid, polyprenoic acid, in patients with hepatocellular carcinoma
30. Adjuvant intra-arterial iodine- 131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
31. Postoperative adjuvant arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma
32. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: A randomised controlled trial
33. Preoperative transcatheter arterial chemoembolisation for resectable large hepatocellular carcinoma. A reappraisal
34. Treatment of unresectable hepatocellular carcinoma: Results of a ranadomised controlled trial
35. Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: Interim analysis
36. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence
37. The living-related liver transplant evaluation: Linking risk factors and outcome
38. Experience from the first 30 living related liver transplants in Hamburg
39. Liver resection - Liver and biliary tumours
40. Liver transplantation for hepatocellular carcinoma
41. Liver transplantation in the treatment of primary liver cancer
42. Liver transplantation for primary hepatic cancer
43. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis
44. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
45. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis
46. Orthotopic liver transplantation
47. Hepatic resection for hepatocellular carcinoma
48. No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis
49. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
50. Hepatic resection versus transplantation for hepatocellular carcinoma
51. Hepatic transplantation for primary and metastatic cancers of the liver
52. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
53. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease
54. Liver transplant for hepatocellular carcinoma - A registry report of the impact of tumor characteristics on outcome
55. Liver transplantation for malignant disease
56. The role of liver transplantation in hepatobiliary malignancy: A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence
57. Disease recurrence following transplantation
58. Liver transplantation for cancer
59. Multimodal adjuvant treatment and liver transplantation for advanced jepatocellular carcinoma. A pilot study
60. Current treatment modalities for hepatocellular carcinoma
61. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients
62. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis?
63. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases
64. Radiofrequency thermotherapy for malignant liver tumors
65. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
66. Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitoring
67. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients
68. Improved survival with percutaneous ethanol injection in patients with large hepatocellular carcinoma
69. Treatment of large HCC: Transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization
70. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection
71. Nonresectional therapies for hepatocellular carcinoma
72. Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma. A study of 37 patients
73. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients
74. Prospective randomised controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
75. Cryogenic surgery: A new method of destruction or extirpation of benign or malignant tissue
76. Cryosurgical ablation of hepatic tumors
77. Treatment of irresectable liver tumours by percutaneous cryosurgery
78. Improved cryosurgery for primary liver cancer
79. Cytoreduction and sequential resection: A hope for unresectable primary liver cancer
80. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study
81. Small hepatocellular carcinoma treated with percutaneous ethanol injection: MR imaging findings
82. Primary hepatic carcinoma resection over 18 years
83. Hepatic resection for hepatocellular carcinoma
84. Hepatic resection in 120 patients with hepatocellular carcinoma
85. Liver resection for hepatocellular carcinoma
86. Hepatic resection for hepatocellular carcinoma
87. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections
88. Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases
89. Surgical treatment of 109 patients wth symptomatic and asymptomatic hepatocellular carcinoma
90. Clinical management of recurrent hepatocellular carcinoma after primary resection
91. Hepatic resection for small hepatocellular carcinoma: The Queen Mary Hospital experience
92. Liver resection for hepatocellular carcinoma: Results of 229 consecutive patients during 11 years
93. Evaluation of 50 consecutive segmental hepatic resections
94. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma
95. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years
96. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
97. Results of hepatic resection for hepatocellular carcinoma
98. Results of 280 liver resections for hepatocellular carcinoma
99. Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992
100. Primary liver cancer in Japan
101. Hepatic resection for hepatocellular carcinoma: Clinical features and long-term prognosis
102. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer
103. Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis
104. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis
105. Hepatocellular carcinoma and cirrhosis - Results of surgical treatment in a European series
106. Primary carcinoma of the liver
107. Prognosis of primary hepatocellular carcinoma
108. Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC
109. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat γ-IFN supplemented with lipopolysaccharide or muramyldipeptide
110. Prognostic factors after hepatectomy for hepatocellular carcinoma. A univariate and multivariate analysis
111. Liver resection for cancer
112. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma
113. Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection
114. Liver resection for hepatocellular carcinoma in the elderly
115. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases
116. Liver transplantation for hepatocellular carcinoma: Clinical results and future aspects
117. Liver transplantation in malignant hepatic neoplasms
118. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver
119. Liver transplantation for hepatocellular carcinoma
120. McMaster P. Role of total hepatectomy and transplantation in hepatocellular carcinoma
121. Treatment of hepatocellular carcinoma
122. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis